Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 1,336 other Healthcare companies
Ranked #409 of 1,337 · scores higher than 69% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including VREX · Click a bar to see the companies
Mainly thanks to its EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.9% | 1.5% | 61% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 9.3% | 4.2% | 77% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -2.6% | -1.0% | 45% | 20% | |
| Book yieldHigher is better · 1,306 reported | 63.6% | 37.9% | 72% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 409 | 1.1B EUR (≈$1.2B) | 69 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 409 | 101.7B BRL (≈$18.3B) | 69 | 58 |
| 409 | 14.41T IDR (≈$893M) | 69 | 69 |
| 409 | 52.7B EUR (≈$58.0B) | 69 | 71 |
| 409 | 787M USD | 69 | 57 |
| 409 | 5.2B CHF (≈$5.9B) | 69 | 69 |
| 422 | 105.8B KRW (≈$76M) | 68 | 41 |
| 422 | 6.5B CNY (≈$911M) | 68 | 62 |
| 422 | 13.8B CNY (≈$1.9B) | 68 | 51 |